This is a prospective study done at Al wasity teaching hospital for reconstructive surgeries in Bagdad in a period from November 2015 to July 2017, using a Total of 119 samples of primary bone tumors which were diagnosed both histopathologically and radiologically. The main objective of this study was to make a comparison between benign and malignant bone tumors. Immunohistochemical staining was done to confirm the diagnosis of primary malignant bone tumors and the proliferative index of them were carefully evaluated. Out of 119 samples of primary bone tumors used in this study, 100 (84%) were benign and borderline (osteoclastoma) and 19 (16%) were malignant, the mean age for benign tumors was lower than the mean age for primary malignant one and both frequently present in the 2nd decade of life, male to female ratio for benign bone tumors was 3/2 and 8.5/1 for primary malignant one, femur was the most common location for benign bone tumors while tibia was the most common bone affected by primary malignant bone tumors. The study also showed that the most common benign bone tumors were osteochondromas (67%) and most common primary malignant bone tumors were osteosarcomas (52.63%), thus this study rise a conclusion that in general, primary bone tumors were mainly benign, occurred predominantly in the second decade of life with a male preponderance. All samples of osteosarcoma, ES/PNET showed a moderate proliferative index when evaluated by ki67 immunohistochemical marker, while a high proliferative index was found in fibrosarcoma and primary NHL of bone.
‫ال‬ ‫خالصـة‬
‫ال‬
Introduction
Bone is the basic unit of the human skeletal system and making a framework for the body, protects the vital organs, supports mechanical movement, contain hematopoietic cells and play a significant role in iron homeostasis [1, 2] . Primary bone tumors are relatively less common among various human neoplasms but are diverse in their pathologic features [3] . The exact incidence of bone tumors is not well known because many benign lesions are not biopsied and recorded [3, 4] . In general when excluding myeloma and lymphoma bone tumors with a malignant biological behavior 75 constitute only 0.2% of all malignancies in adults and approximately 5% of childhood malignancies [4] . Close cooperation is needed between the histopathologist, radiologist, surgeon and oncologist in order to diagnose bone tumor properly and make a management decision [5, 6] . The nomenclature and classification of primary bone tumors is based mainly on the pathway of tumor cell differentiation which is usually identified by the connective tissue matrix made by tumor cells [7] . The histogenesis of many primary bone tumors however is not well confirmed and a number of bone tumors are classified by distinct morphological or clinicopathological features (e.g., osteoclastoma giant cell tumor of bone) or by molecular genetic abnormalities (e.g., Ewing's sarcoma) [7, 8] . Radiological information is mandatory for bone tumor diagnosis and it is highly recommended that wherever possible, the pathologists should have a radiological knowledge allowing them to personally see the radiological images of a bone tumour before establishing the final diagnosis. Otherwise, it should be recorded in the pathology report [9, 10, 11] .
Materials and methods
This study is a prospective study carried out at Al-Wasity teaching hospital for plastic and orthopedic surgery in Bagdad (the period from November 2015 to July 2017) using a total of 119 cases of primary bone tumors which were diagnosed at histopathological and radiological aspects according to the recent WHO classification of bone tumors [10] . In orthopedic diseases OPD, patients clinically presented with bone mass were included in this study and X-ray of the affected bone had been taken while CT scan and MRI were done according to the need and advice of orthopedic surgeon. Biopsy was taken mainly by scrapping method, incision and excision. In laboratory department, any soft tissues present were fixed in 10 % formalin while for bone, 3 to 5 mm thick sections were made and fixed in 10% buffered formalin and then decalcification was done by placing the specimens in nitric acid for adequate time. After that all tissues were processed by the same routine basic method recommended for histopathological study, then all slides were examined under light microscope and different types of primary bone tumors were identified. Cases of secondary bone tumors were excluded. Clinical information include radiological features, age, sex and location of tumors were taken from the biopsy request forms. Some primary malignant bone tumors required diagnostic confirmation immunehisto-chemically [10] . Therefore, all of the paraffin embedded tissues which are diagnosed as primary malignant bone tumors were subjected to immunohistochemical staining using autostainer (X biogenex i6000) to confirm the diagnosis as shown in Tables 1  and 2 . Results of immunohistochemical study were interpreted based on the following scoring protocols: CD99: − if absent; + between (0% -10%) of tumor cells; 2+ if more than 10% and less than 50% of tumor area; and 3+, if 50% and\or more of tumor cells were positive [12] . Desmin: negative when no immunoreactivity was seen, focal/weak if less than 20% were positive and positive if strong positivity was seen in equal and more than 20% of tumor cells [13] . ki67: the scores were regarded as negative according to the percentage of nuclear reactivity (0% of nuclei stained), low (less than 10%), moderate (10%-40%), and high (more than 40%).Only nuclear staining (plus mitotic figures which are stained by Ki67) in hot spots, (areas in which Ki67 staining is particularly prevalent) should be incorporated into the Ki67 score [13] . Vimentin: Tumors were considered to be positive when stained at least 10% of the neoplastic cells. A cut-off < 10% of positive tumor cells was used to identify negative cases [14] . S100: the score were (0 to 2), with a score of 0 indicate no staining, a score of 1 indicate focal nuclear staining, and a score of 2 indicate staining in the majority of tumor nuclei [15] . CD45: immunohistochemical stains were interpreted as positive if at least 10% of the neoplastic cells showed intense immunereactivity. Specimens were considered focally positive if immunoreactivity was identified within the cells of interest but comprised less than 10% of the tumor [16] . CD3 and CD20: the positive results defined by the presence of at least 10% of antigen expressing cells [17] .
Results and Discussion
This study enrolled 119 samples of primary bone tumors, 100 were benign and borderline tumors (osteoclastomas) and 19 were malignant as shown in Figure 1 . Regarding benign tumors, 60(60%) were male and 40(40%) were female with male \female ratio 3\2 .Their age range from 2.5 years to 50 years with a mean age of 16.66 ± 9.51 years, they were divided into six age groups each group reflects a decade of life from the 1 st decade to the 6 th decade, the results were respectively 25, 43, 21, 7, 3 and 1 as shown in Table 3 . Topographically 76(76%) tumors involved the upper extremity, 22(22%) involved the lower extremity and only two (2%) involved the axial skeleton. The distribution of samples according to bone location indicate that the most common bone affected in benign bone tumor was femur represent 40% of samples followed by tibia represent 30% of samples. Histologically, benign bone tumors in decreasing order of frequency were shown in Table 4 . The study found that the most common benign bone tumor was osteochondroma which appeared microscopically as normal bony trabeculae covered by a cartilage resemble disorganized growth plate with ossification toward the base as shown in Figure 2 , the mean age was 15.64± 4.61, with a slight male predominance, most frequently involve femoral bone. Among 19 cases of primary malignant bone tumors, the study showed that 17 (89.47%) were male and only two(10.52%) were female with a male to female ratio 8.5/1, their age range from 8 to 83 years with a mean age of 21. 21± 17 years. According to the age interval from the 1 st to the 6 th decade, the results were respectively 1, 11.4, 2, 0, 0 and only one sample were 83 years old which was a male with primary NHL of bone in which the final diagnosis was made after a careful search done by the clinician to exclude the presence of any other primary foci (as shown in Figure 11 ). Figure 4 ) with no clinical malignancy according to the microscopic grading of giant cell tumors [10] .
Topographically, 13 (68.42%) located in the lower extremity, 4 (21%) located in the upper extremity and only 2 (10.52%) in axial skeleton. Tibia was the most common site in the percentage of 31.57%, followed by femur 21%. The most common primary malignant bone tumor was osteosarcoma (which appeared histologically as malignant spindle cell tumors producing osteoid unconnected with cartilage). The mean age was 12.1 ±2.7 years, with a male to female ratio was 9\1, most commonly affect femoral bone of 10 sample of osteosarcomas, seven were conventional, one was chondroblastic, one osteoblastic and one telangectatic (as shown in Figure 8 ). All cases of osteosarcomas immunohistochemecally were evaluated using non-specific markers because of unavailability of markers of osteoblastic differentiation such as osteocalcin, osteonectin, SATB2 at our center and in all cases of osteosarcoma included in this study the diagnosis was straight forward due presence of abundant osteoid directly produced by tumor cells without an intervening areas of cartilage and confirmed radiologically. The 2 nd most common primary malignant bone tumors was ES\PNET which appeared microscopically as a sheet of undifferentiated small round uniform cells with scant cytoplasm, indistinct cell membrane and minimal amounts of stroma (as shown in Figure 10 ), all cases affecting males, half of the cases involve tibia and the other half involve radius. The results of immunehistochemical staining of primary malignant bone tumors are shown in Table 7 . Accordingly, osteosarcoma ewing sarcoma and chondrosarcoma had a moderate proliferative index and the strong proliferative index was observed in primary fibrosarcoma and nonHodgkin lymphoma of bone. CD3,CD45,desm in : well differentiated chondrosarcoma in a 37 years old femaleA: histological picture x100, B: immunohistochemical stain with S100 showed score 2 positive nuclear stain x100,C: moderate nuclear staining for ki67 x400 
The Discussion
In the WHO classification, most bone neoplasms are classified as either benign or malignant. Although a sharp distinction between these two categories is feasible in most of them, some neoplasm exhibit borderline and intermediate characterstics as osteoclastoma (GCTs) [10] , which have been described as the most challenging benign bone tumors because it shows a tendency for significant bone destruction, local recurrence and occasionally metastasis [18] . The present study showed that 84% of all sample were benign and only 16% were malignant which agree with one study done by Sunita et al. (2015) [19] , but another study done by Karun et al. (2011) [20] showed that only (57.26%) of the bone tumors were benign, may be due to a non-random selection of samples used by the latter. The mean age range for benign bone tumors was lower than that of primary malignant tumors and the most common presentation for both was in the 2 [19, 20] . In general bone tumor commonly affect male with a male to female ratio much higher in primary malignant bone tumors which agree with sunita et al. (2015) [19] . The most common location in benign bone tumors was femur, while in malignant bone tumors was tibia, the result disagree with sunita et al. (2015) [19] in which it showed femur was the most common location for both benign and malignant bone tumors followed by tibia. The most common benign bone tumor was osteochondroma with a male predominance and commonly affect femoral bone results agree with results of sunita et al. (2015) and karun et al. (2011) [19, 20] , but the latter studies in contrast to this study showed that giant cell tumors were the second most common types. Although, osteochondroma in this study found to be the most common benign bone tumor, but in our center it presented with a much higher percentage (67%) than in many studies worldwide [19, 20, 21, 22, 23] in which the highest percentage reported among them was 34%. This study also showed the most common primary malignant bone tumors was osteosarcoma commonly involved femoral bone and the second decade of life regarded as the most common age of occurrence, the results agree with one Iraqi study by Kareem et al.
(2010) [21] , but the latter study showed a slight male predominance in contrast to this study which showed a strong male predominance (90% of patients were males) may be merely due to variation in sample size or may indicate a recent rise in its incidence among Iraqi males. [19, 20] , but in contrast to the latter studies, surprisingly all cases in this study were males.
Conclusion
This study showed that in general primary bone tumors were mainly benign, occurred predominantly in the second decade of life with a male preponderance. The mean age for malignant bone tumors were more than for benign one although both frequently occurred in the 2 nd decade of life, tibia was the most common location for malignant tumor while femur was the most common in benign one. Primary malignant bone tumors showed a strong male preponderance in contrast to a slight male preponderance occurred in benign tumors. Osteosarcoma and osteochondroma were the most common primary malignant and benign bone tumor respectively. All samples of osteosarcoma, ES/PNET showed a moderate proliferative index when evaluated by ki67 immunohistochemical marker, while a high proliferative index was found in fibrosarcoma and primary NHL of bone.
